|
| Exchange Disseminated Time 25/01/2018 18:29:57 | Amrutanjan Health Care Ltd has informed BSE that a meeting of the Board of Directors is scheduled to be held on February 13, 2018, inter alia, to consider and approve the following:
1. Sub- division of equity shares of face value of Rs. 2/- each.
2. Un-audited Financial Results along with the Limited Review Report for the quarter and nine months ended December 31, 2017.
3. Declaration of Second Interim Dividend for the financial year 2017-18.
In view of the above, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 and e Company’s Code of Conduct to regulate, monitor and report trading by insiders the trading window for dealing in the securities of the Company shall remain closed for the Specified Persons (Directors & Designated Employees) from January 26, 2018 to February 15, 2018 (both days inclusive). |
|
|